Abstract
Purpose: To investigate the clinical characteristics, endocrinological function, and etiologies of patients with bilateral adrenal lesions.
Methods: A retrospective study of 777 patients with bilateral adrenal lesions was conducted at the Chinese General Hospital of the People’s Liberation Army between January 2013 and January 2018. Patient demographic features, hormonal profiles, imaging findings, and histopathological findings were reviewed from the database records.
Results: Of the 777 patients, 495 were men, and the mean age at diagnosis was 52.0±13.0 years. A total of 511 (65.8%) cases were benign, followed by adrenal metastases (n=224, 28.8%), pheochromocytoma (n=26, 3.3%), adrenal lymphoma (n=9, 1.2%), and adrenal corticocarcinoma (ACC) (n=7, 0.9%). Hormonal evaluation revealed that 34.3% of bilateral adrenal lesions were functional. The primary etiologies of functional lesions were primary aldosteronism (16.6%) and PBMAH (8.8%). Patients with lymphoma and metastases were significantly older and possessed larger masses than those with benign nonfunctional lesions (P<0.001).
Conclusion: Benign adrenal lesions and metastases to the lungs are the most common causes of bilateral adrenal lesions. Primary aldosteronism and BMAH are the most prevalent functional lesions. Older age and larger mass size are significant indicators of malignancy.
Introduction
Adrenal lesions are a common incidental finding in modern medicine, appearing in up to 5% of CT scans. However, most clinical knowledge focuses on unilateral (single-sided) lesions. Bilateral adrenal lesions—where both glands are affected—are rarer and clinically more complex. The challenge for clinicians is determining whether these bilateral masses are harmless "incidentalomas," signs of a systemic malignancy (metastases), or the cause of serious endocrine disorders like Cushing’s syndrome or primary aldosteronism. This study seeks to provide a definitive etiological spectrum using a massive, single-center dataset of 777 patients.
Methods
The researchers conducted a retrospective analysis of 777 patients treated at the Chinese General Hospital of the People’s Liberation Army between 2013 and 2018. To classify the lesions, the team used a multi-modal approach:
- Endocrine Investigation: Extensive biochemical testing (including plasma cortisol, ACTH, renin, and aldosterone) to determine functional status (hormone overproduction).
- Imaging: Analysis of CT, MRI, and FDG-PET/CT scans to assess the size, texture, and "washout" patterns of the masses.
- Histopathology: Biopsies or surgical results were used to confirm diagnoses of malignancy (like ACC or lymphoma) and specific benign conditions.
Key Results
Etiological Breakdown
The study found that while nearly two-thirds (65.8%) of bilateral adrenal lesions are benign, nearly 30% are metastatic. Lung carcinoma was the primary source of metastasis, accounting for 19.1% of the total cohort. Rare but critical malignancies identified included pheochromocytoma (3.3%), lymphoma (1.2%), and adrenocortical carcinoma (0.9%).
Functional Characteristics and Physical Markers
One of the most significant findings is that 34.3% of bilateral lesions were hyperfunctional, a higher proportion than typically seen in unilateral cases. Among the 267 functional cases, Primary Aldosteronism (16.6%) and Primary Bilateral Macronodular Adrenocortical Hyperplasia (PBMAH, 8.8%) were the most prevalent.
Physical characteristics also served as strong diagnostic indicators. The study found a clear correlation between lesion size, patient age, and etiology. Malignancies such as lymphoma and metastases were associated with significantly older patients (averaging ~58-60 years) and larger mass sizes compared to benign non-functional lesions.
Discussion and Future Work
The authors acknowledge limitations such as single-center referral bias and the use of imaging-based diagnoses for some benign cases. However, the scale of this cohort provides robust evidence for clinical practice. Future research should focus on the genetic alterations, such as ARMC5 mutations, that drive bilateral growth and hormone overproduction. Clinically, the findings reinforce the need for thorough chest imaging and comprehensive endocrine screening when bilateral adrenal masses are discovered.
Summary updated